lercanidipine has been researched along with Chronic Lung Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gül, S; Hüseynov, İ; Milletsever, A; Selçuk, E; Selli, J; Tepebaşı, MY | 1 |
1 other study(ies) available for lercanidipine and Chronic Lung Injury
| Article | Year |
|---|---|
Lercanidipine alleviates doxorubicin-induced lung injury by regulating PERK/CHOP and Bax/Bcl 2/Cyt c pathways.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Doxorubicin; Inflammation; Lung Injury; Rats | 2023 |